ALNY vs ASND: stock comparison and AI forecast
Alnylam Pharmaceuticals, Inc. (ALNY) and Ascendis Pharma A/S (ASND) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALNY Alnylam Pharmaceuticals, Inc.
- Price
- $158.00 -47.0% · 6M
- Market Cap
- $21.14B
- P/E Ratio
- 7.4x
- Size
- large-cap
- AI Forecast
ASND Ascendis Pharma A/S
- Market Cap
- $16.35B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALNY is 1.3 times larger than ASND by market capitalization ($21.14B against $16.35B).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALNY | ASND |
|---|---|---|
| Market Cap | $21.14B | $16.35B |
| P/E Ratio | 7.43x | – |
| P/B Ratio | 5.87x | – |
| EPS | $21.27 | $-15.40 |
| Book Value/Share | $26.93 | – |
| Revenue/Share | – | $20.59 |
| FCF/Share | – | $-0.10 |
Profitability & Margins
| Metric | ALNY | ASND |
|---|---|---|
| ROE | 76.8% | – |
| ROA | 34.6% | – |
| ROIC | 22.7% | -121.1% |
| Gross Margin | 78.7% | 86.1% |
| Operating Margin | 21.5% | -23.7% |
| Net Margin | 44.2% | – |
| EBT Margin | 17.5% | -33.4% |
| Tax Rate | -174.3% | -6.0% |
Financial Health
| Metric | ALNY | ASND |
|---|---|---|
| Current Ratio | 2.48x | 1.04x |
| Quick Ratio | 2.43x | 0.76x |
| D/E Ratio | 1.22x | – |
| Financial Leverage | 2.22x | – |
| Interest Coverage | 4.7x | – |
| Working Capital | $3.05B | $47M |
Cash Flow
| Metric | ALNY | ASND |
|---|---|---|
| Operating Cash Flow | $1.23B | -$2M |
| Free Cash Flow | – | -$7M |
| Capital Spending | – | -$5M |
| FCF/Sales | – | -0.5% |
| CapEx/Sales | – | 0.3% |
Operational Efficiency
| Metric | ALNY | ASND |
|---|---|---|
| Asset Turnover | – | 0.92x |
| Inventory Turnover | 12.6x | 0.6x |
| Fixed Assets Turnover | – | 8.1x |
| Days Inventory | 29 days | 662 days |
| Payables Period | 37 days | – |
Income Statement
| Metric | ALNY | ASND |
|---|---|---|
| Total Revenue | – | $1.35B |
| Operating Income | $1.35B | -$320M |
| Net Income | $2.77B | – |
| R&D Expense | $1.92B | $599M |
| SG&A Expense | $1.66B | $884M |
| Cost of Goods Sold | $1.33B | $188M |
Dividend & Shareholder Information
| Metric | ALNY | ASND |
|---|---|---|
| Shares Outstanding | 134M | 66M |
ALNY vs ASND: stock comparison and AI forecast
Which is bigger, ALNY or ASND?
ALNY is 1.3 times larger than ASND by market capitalization ($21.14B against $16.35B).
Which one does Intratio's AI model rank higher, ALNY or ASND?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.